# Complex Abdominal Surgery: Whipple Pathway (2026)
> **Status:** Draft. In process, not final.
> **This is a guideline. It does not replace clinical judgment.**
---
## Contents
1. [[#1. Timeline at a Glance|Timeline at a Glance]]
2. [[#2. Indications and Operative Options|Indications and Operative Options]]
3. [[#3. Pre-operative Optimization|Pre-operative Optimization]]
4. [[#4. Morning of Surgery|Morning of Surgery]]
5. [[#5. Intra-operative Care|Intra-operative Care]]
6. [[#6. End of Surgery|End of Surgery]]
7. [[#7. Immediate Post-op (POD 0) – ICU vs. Ward|Immediate Post-op (POD 0): ICU vs. Ward]]
8. [[#8. Standing Inpatient Orders (All PODs)|Standing Inpatient Orders (All PODs)]]
9. [[#9. Day-by-Day Changes|Day-by-Day Changes]]
10. [[#10. Geriatric Considerations (Age > 65)|Geriatric Considerations (Age > 65)]]
11. [[#11. Discharge|Discharge]]
12. [[#12. Complications|Complications]]
13. [[#13. References|References]]
14. [[#14. Appendix – Abbreviations|Appendix: Abbreviations]]
---
## 1. Timeline at a Glance
| POD | Key milestones |
|---|---|
| **0** | Extubate in OR if possible. Epidural with sufentanil only (no local). NPO. LR 100–125 mL/hr. Zosyn continues to 24 h from incision. |
| **1** | Remove central line if unused. With APS, add local (e.g., bupivacaine) to epidural if HD stable. Start enoxaparin QHS. NGT may come out (**not** after a prolonged case or vascular resection). |
| **1–2** | Start ASA 81 mg daily (listed under Vascular). Advance diet from clears. Nutrition consult. |
| **2** | Serum lipase. Remove primary dressing. |
| **3** | Serum and drain amylase; remove drain if drain amylase < 3× serum. Start metoclopramide. Consider gentle diuresis. **NGT out by POD 3 at the latest.** Remove scopolamine patch by POD 3. |
| **4** | Remove Foley. Vascular duplex of resected vessels once bowel function returns (~POD 4). |
| **5–10** | **Highest risk for sentinel bleed.** |
| **7** | Epidural out by POD 7 (sooner if progressing well). |
---
## 2. Indications and Operative Options
### Indications
1. Mass in the pancreatic head (malignant, neuroendocrine, IPMN)
2. Cholangiocarcinoma
3. Ampullary carcinoma
4. Duodenal malignancy proximal to or invading the pancreas
5. Severe chronic pancreatitis involving the pancreatic head
### Operative Options
The choice is often made intra-op, based on extent of involvement and ability to get clear margins.
| Procedure | Description | Key risks |
|---|---|---|
| **Standard Whipple** | Distal stomach (pylorus) resected | Dumping syndrome; vitamin deficiencies |
| ↳ **WATSA** variant | Used when tumor encases the SMV and/or PV **and** prevents complete dissection of the retropancreatic tunnel under the pancreatic neck. Requires a non-standard tunnel under the splenic vein; takes more pancreatic tissue. | More extensive dissection |
| **Pylorus-preserving Whipple** | Stomach fully preserved | Higher risk of DGE |
---
## 3. Pre-operative Optimization
### Labs (usually part of the workup)
- **A1c**
- **Vitamin D, zinc, iron**
- **CA 19-9**
- Draw only with normal total bilirubin and no evidence of pancreatitis; both falsely elevate it.
- Half-life is about 10 days, so draw the baseline at least 10 days after biliary stenting.
- About 15% of patients don't make CA 19-9, so a normal result does **not** mean no disease. Consider proxy markers (CEA, CA-125).
- **Albumin/prealbumin**, checked with CRP
- **Routine:** CMP, CBC, type for possible transfusion
### Chronic Conditions
- **Diabetes:** Optimize with PCP or Endocrinology. Target **A1c ≤ 7.2**. Type III (pancreatogenic) diabetes can be hard to control.
- **Cardiac:** Cardiology visit pre-op, depending on severity of cardiac history.
- **Pulmonary:** Pulmonary consult, depending on severity of lung disease.
### Vascular Diagnostics
- **Vein mapping for ALL patients**, in case vascular reconstruction is needed
- **LE duplex** if there is edema or concern for DVT
### Nutrition
- **ESI shakes:** Start 5 days pre-op. Take 2–3 per day **in addition to** meals (they don't replace meals). Sold as a 15-pack. **None on the morning of surgery.** Modify for patients with any type of diabetes.
- **Refer to Adult Medical Nutrition Therapy** if the patient has cancer or nutritional concerns.
- **Diet:** At least 3 meals a day (or 4–6 smaller meals), with protein at every meal. Favor lean protein, complex carbohydrates and whole grains, and fruits and vegetables. Avoid alcohol, smoking, and high-fat foods.
### Prehabilitation ([ACS Strong for Surgery](https://www.facs.org/quality-programs/qi-resources/strong-for-surgery/))
- If there are concerns about mobility or endurance, place an internal "Consult to Physical Therapy" for prehab. OHSU PT can refer to local PT.
- Encourage frequent walks and staying active.
- Exercise during neoadjuvant chemo and before surgery improves surgical outcomes and overall survival.
### Smoking and Alcohol
- **Smoking:** Stop at least 4 weeks pre-op and stay off at least 2 weeks post-op. Prescribe NRT if needed.
- **EtOH:** Screen for past and current use. If history is concerning, order **PEth** to verify cessation. Coordinate guided weaning with the PCP if needed.
### Medications
| Medication | Instruction |
|---|---|
| Vitamin E, NSAIDs (aspirin, Advil, Aleve, ibuprofen), herbal supplements | Hold **7 days** pre-op unless directed otherwise (bleeding risk) |
| Warfarin, P2Y12 inhibitors (clopidogrel, ticagrelor, prasugrel), DOACs (apixaban, rivaroxaban, dabigatran) | **Ask about these specifically.** Stop anticoagulation **72 h** pre-op so neuraxial blocks can be placed safely (ASRA guideline). |
| Acetaminophen | OK to use pre-op |
### Hygiene
- **Hibiclens shower** the night before and the morning of surgery, per the pre-op packet. The clinic RN provides the soap.
- **Oral care:** Brush teeth, gums, and tongue the night before and the morning of surgery.
### Special Referrals
- **Age > 80 or frail:** Place an outpatient order for "Consult to Internal Medicine" with free text: *Attn: Dr. Mary Brooks, Transitional Care Clinic.*
- Frailty is assessed with the **RAI** by PMC or in Dr. Sheppard's clinic.
- Refer anyone **> 70 with an elevated frailty score** to Dr. Brooks.
- **Age < 18:** Place "Consult to Pediatric Pain" to plan pain management.
### Orders
- Order set: **GS: PANCREATIC SURGERY: PRE-OP**
- In clinic, place a **COR** and a **consult to Anesthesia** for epidural placement on the morning of surgery.
---
## 4. Morning of Surgery
- **Diet:** Confirm clear liquids only after midnight. Clear liquids are OK until 1 h before arrival at OHSU.
- **Medications:** Confirm the right medications were held, especially blood thinners.
- **Labs:** If there is any history of thrombocytopenia, consider an urgent CBC before the epidural.
---
## 5. Intra-operative Care
### Lines
- **Central line:** Consider one, usually an **8/9 Fr introducer**. Triple lumens can't be used for rapid infusion (e.g., Belmont). All patients with a known need for vascular resection get an introducer unless contraindicated.
- **Arterial line**
- **Large-bore IV**
### Drains and Tubes
- Foley
- NGT (the surgical team confirms position in the OR)
- Blake drain (placed by surgery near the end of the case)
### Fluids
- Guide fluids by hemodynamic parameters. The goal is **euvolemia**; avoid excess crystalloid.
- **Before incision,** discuss balanced resuscitation with the anesthesia provider, including colloid and hypertonic saline.
- **Hypertonic saline:**
- Don't start if Na > 145.
- Run at 100–125 mL/hr and check Na every 90–120 min.
- Stop as Na approaches 150.
### Hypotension
- Confirm euvolemia first. Epidurals with local anesthetic can cause hypotension through sympatholysis, so rule that out.
- **If pressors are needed, communicate with the surgeon.**
### Antibiotics
- **Piperacillin/tazobactam (Zosyn) 4.5 g q2h** from incision to closure. After closure, switch to q8h extended infusion until a total of 24 h from incision.
- **PCN allergy:** vancomycin + ciprofloxacin + metronidazole
### Cultures
- Send bile for culture. It doesn't change immediate management, but it guides antibiotic choice if a post-op infection develops.
---
## 6. End of Surgery
- **Lines:** Anesthesia orders a CXR and follows up to confirm the lines are placed correctly and OK to use.
- **Orders:** Use the order set **GS: Pancreatic Surgery: Post-Op (PO-7746)**.
- Age > 65: use geriatric-preferred medications (see [[#10. Geriatric Considerations (Age > 65)|§10]]).
- **Avoid scopolamine patch if age > 65.** If one is ordered, remove it by POD 3. Withdrawal causes nausea, headache, dizziness, and confusion; treat with meclizine 50 mg PO q6h.
- **Antibiotics:** Confirm Zosyn continues to 24 h from incision: 4.5 g load, then 4.5 g q8h extended infusion. Usually only 1–2 more doses.
- **Respiratory:** Extubate in the OR. After a prolonged operation, the patient may go to the ICU intubated.
- **NGT:** Leave it in if DGE is expected. Remove by **POD 3 at the latest**.
---
## 7. Immediate Post-op (POD 0) – ICU vs. Ward
> **Communicate with the primary team (chief or junior resident), day or night, about ANY question or concern.**
| | **OR → ICU** | **OR → Ward** |
|---|---|---|
| **Handoff** | If still intubated, TSICU meets anesthesia at the bedside for report and clarifies why. | — |
| **Respiratory** | Watch for distress (atelectasis, poor pain control, underlying lung disease). Extubate as soon as safe. TSICU manages the ventilator. **Avoid BiPAP/CPAP**, which puts air in the stomach and pressure on the anastomosis. | — |
| **Epidural** | Sufentanil at 2 mL/hr. **No local anesthetic** unless discussed with the surgery attending (risk of hypotension and excess fluid). This rate often isn't enough; if extubated and not oversedated, increase within ordered parameters. | Same solution and rate, titrated within ordered parameters. If pain stays > 5/10 despite titration, call **APS**. If oversedated, turn down to 1 mL/hr rather than off (to avoid dysfunction). If it must be turned off, notify APS. |
| **Pain goal** | < 5/10 | < 5/10 |
| **If intubated** | IV opioid PRN, managed by TSICU | — |
| **No epidural** | Hydromorphone PCA or IV pushes. Hydromorphone is preferred if > 65. Avoid morphine in CKD. | Same |
| **Acetaminophen** | 1000 mg TID, PO or IV if NGT present | Same |
| **Hypotension** | Very common. Usually hypovolemia (oliguria is a sign). Give boluses on top of maintenance; be judicious in heart failure. Other causes: bleeding, analgesia/sedation. **FYI surgery if > 2 L of boluses overnight.** Norepinephrine is the preferred pressor; **FYI surgery before starting pressors.** | Hypotension and oliguria are very common and should respond to boluses. **Up to 1.5 L of crystalloid boluses overnight** (judicious in heart failure). **Call surgery if not responding or if > 1.5 L is needed.** |
| **Anemia** | Common (blood loss, fluid shifts). Avoid transfusion when possible; the goal is Hgb > 7. **Discuss any transfusion with surgery.** | Same |
---
## 8. Standing Inpatient Orders (All PODs)
These apply from POD 0–1 until discharge unless the day-by-day section says otherwise.
| Domain | Standing order |
|---|---|
| **Analgesia** | Acetaminophen 1000 mg TID. Lidocaine patches × 2, one on each side of the incision. |
| **Urinary** | **Tamsulosin 0.4 mg QHS, PO only (never through an enteric tube), for all genders** |
| **GI prophylaxis** | Pantoprazole 40 mg IV daily → PO once tolerating clears or progressing well |
| **Glucose** | Mild vs. moderate sliding-scale insulin with CBG checks. Consult the **Glycemic team** if the patient is diabetic or has persistent post-op hyperglycemia (BG regularly > 180). |
| **Labs (from POD 1)** | Daily CBC (no diff unless infection is a concern), renal panel, and Mg. LFTs daily × 3 days. |
| **Blake drain** | Bulb self-suction. Confirm it is holding suction. **Do not strip.** |
| **Femoral vein harvest** (if vascular reconstruction) | Flexmaster wrap on the harvested leg and SCDs on both legs. From POD 3, Vascular takes down their own dressing. |
| **GI monitoring** | Watch for **DGE**: burping, hiccups, abdominal distention. |
| **Activity** | HOB > 30°. SCDs while in bed. IS 10 breaths/hr while awake. |
| **Hygiene** | Help with toothbrushing BID. Bed bath PRN. **No showering until the epidural is out.** |
| **Delirium prevention** | Limit nighttime stimulation to allow uninterrupted sleep. Make sure assistive devices are available (hearing aids, glasses, dentures). From POD 1, melatonin 3 mg QHS PRN. |
| **Discharge planning (from POD 1–2)** | Review with the Case Manager for barriers (SNF, TPN, transportation, housing). |
---
## 9. Day-by-Day Changes
### POD 0–1 (ICU and Ward)
- **Lines:** Confirm and approve every line (central, PICC, NGT, DHT, etc.), and make sure each line and drain has an Epic order. **ICU removes the arterial line and introducer sheath before ward transfer.**
- **Drain output:** Sanguineous to serosanguineous at first. After heavy resuscitation, output can be very high and increasingly serous (the patient is effectively diuresing through the drain).
- **Foley:** Stays in until POD 4 to track urine output through fluid shifts.
- **NGT:** May come out on POD 1 depending on clinical status and output. **Do NOT remove on POD 1 after a prolonged operation or vascular resection.**
- **Fluids:** LR 100–125 mL/hr for at least the first 12 h, plus boluses for hypotension or oliguria.
- **Pain (POD 1 AM):** With APS, add local (e.g., bupivacaine) to the epidural if HD stable. The opioid can stay sufentanil or switch to hydromorphone.
- **Antibiotics:** Zosyn 4.5 g q8h (4-h extended infusion) until 24 h from incision. **Not compatible with LR**; if there is only one IV, switch IVF to NS temporarily.
- **Glucose:** Continue Endotool if it was started in the OR, and transition off when able.
- **Wound:** Leave the primary dressing on and watch for strikethrough. Change it only if strikethrough is significant. Change the drain-site dressing daily and PRN.
- **Diet:** NPO. Sips of water with select meds are OK.
- **Activity:** If HD stable, sit at the edge of the bed, then up to the chair. Check orthostatic BP the first time out of bed.
### POD 1–2
- **Lines:** Remove the central line on POD 1 if it is not in active use. Make sure there is at least 1 PIV first.
- **Drain output:** Becoming more serosanguineous.
- **NGT:** May come out depending on status and output.
- **Fluids:** Wean IVF as PO intake and volume status allow.
- **Pain:** With APS, the epidural can be changed to local only, opioid only, or a combination. RNs titrate within set parameters. If pain is uncontrolled, discuss with APS. Consider **tizanidine**.
- **New meds:** **Enoxaparin prophylaxis starting POD 1 QHS.**
- **Vascular:** Start **ASA 81 mg chewable daily** (PR if no PO route) on POD 1 or 2.
- **Labs:** **Lipase on POD 2** (post-op pancreatitis). Plan **drain and serum amylase for POD 3**.
- **Wound:** Remove the primary dressing on **POD 2**.
- **Diet:** Advance gradually: clears → full liquids → regular soft (no red meat). Watch for return of bowel function. **Consult nutrition** for assessment and post-Whipple diet education.
- **Activity:** Out of bed and in the chair 2–3×/day (sling if needed), with short walks as able. Check orthostatics if dizzy.
### POD 3–6
- **Lines:** Keep PIVs for access.
- **Drain:**
- Output clears from serosanguineous to serous.
- **Notify the primary team for any NEW blood in the drain** (see [[#Sentinel Bleed]]).
- **Remove the drain if drain amylase is < 3× serum amylase (both checked POD 3).**
- **Foley:** Remove on **POD 4** unless there are other concerns. With an epidural in place, retention risk is about 50%. Have a low threshold to replace it; if replaced, keep it until the epidural is out.
- **NGT:** May come out depending on status and output.
- **Fluids:** IVF should be off unless the diet can't be advanced. Consider **gentle diuresis on POD 3** (e.g., furosemide 10–20 mg IV × 1) and monitor the response, aiming for euvolemia. Daily weights (standing strongly preferred).
- **Pain:**
- **Epidural out by POD 7**, sooner if progressing well. APS manages the transition and its orders.
- Transition to **oxycodone PO q3–4h**: **< 65 y: 5–10 mg; > 65 y: 2.5–5 mg.** Ideally the patient tolerates at least full liquids first.
- If pain is hard to control, add **ibuprofen 600 mg TID** (no more than 2 weeks total), or IV ketorolac if no PO.
- **New meds:**
- **Metoclopramide 5 mg PO TID starting POD 3** (IV if N/V), increasing to 10 mg if needed. See the geriatric guidance.
- **Pylorus-preserving Whipple:** consider IV erythromycin; also consider prucalopride.
- **Pancreatic enzymes:** Restart home enzymes once on a regular diet. **Many patients need PERT post-op even if they didn't before.**
- **Once passing flatus:** senna 1 tab BID + PEG (MiraLAX) 17 g daily, plus bisacodyl suppository daily PRN.
- **Labs:** Serum and drain amylase on POD 3. Daily CBC, renal panel, and Mg.
- **Wound:** Confirm the midline wound is healing well.
- **Vascular:**
- **Duplex of resected vessels** once bowel function returns (~POD 4). The patient must be NPO 4–6 h beforehand (bowel gas obscures the view), so make them **NPO at MN and order the scan for 0600**.
- **Continue ASA 81 mg daily for 3 months.**
- **Diet/GI:**
- Protein supplements: **clears → Protein 2.0; full liquids → a high-protein, low-sugar, low-calorie supplement** (e.g., Premier Protein).
- **Diarrhea:** De-escalate bowel meds first. Check *C. diff* when appropriate (see the [Diarrhea Decision Tree](https://ohsu.ellucid.com/pman/documents/view/10050)).
- **Persistent diarrhea mostly after meals** (± bloating, gas pain) suggests **EPI**. Have a low threshold to start **Creon**; fecal elastase can be checked.
| Weight | Meals | Snacks |
|---|---|---|
| > 70 kg | 36,000 units × 2 | 36,000 units × 1 |
| < 70 kg | 24,000 units × 2 | 24,000 units × 1 |
- Follow up on nutrition recommendations (e.g., vitamin labs).
- **Activity:** Continue PT/OT. The patient should be out of bed most of the day, with 2–3 walks/day.
- **Discharge planning:**
- If the Glycemic team is involved, give them a best-guess discharge date so they can make discharge recommendations and start diabetic teaching.
- **Send meds with likely coverage problems to PPV ASAP** (e.g., Creon, apixaban, prucalopride).
### POD 7+
- **Lines:** Keep PIVs until discharge.
- **Drain:** Should be out by now unless there is an ongoing pancreatic fluid leak.
- **Foley:** If it was replaced, try removing it again before discharge.
- **Fluids:** IVF off unless the diet can't be advanced. Continue diuresis if still hypervolemic.
- **Pain:** Move to all-PO meds and start teaching how to wean pain medication.
- **Meds:** Restart home Creon once on a regular diet, or add it for signs of pancreatic insufficiency. Continue metoclopramide 5 mg PO TID (IV if N/V).
- **Labs:** Daily renal panel and Mg. Daily CBCs can stop if values are stable and normal.
- **Glucose:** Stop sliding-scale insulin when insulin hasn't been needed, CBGs are < 180, and the patient is on a regular diet. If Glycemic is following, tell them discharge is close and get their recommendations and diabetic teaching.
- **Diet/GI:** Same as POD 3–6. Pancreatic elastase isn't required before starting enzymes but helps confirm why stools are loose. Consider an outpatient referral for medical nutrition therapy.
- **Hygiene:** **Help the patient shower before discharge** so they're comfortable doing it at home. The midline incision doesn't need to be covered.
- **Discharge planning:** Prior authorizations can take several days, so send meds to PPV early.
---
## 10. Geriatric Considerations (Age > 65)
**Goal:** Reduce the risk of delirium, oversedation, urinary retention, renal insufficiency, and QT prolongation.
| Category | Preferred | Avoid / caution |
|---|---|---|
| **Epidural** | Primary pain control. Hydromorphone is the preferred opioid, ± bupivacaine. Some opioid-sensitive patients do better on bupivacaine only (if HD stable). | — |
| **Multimodal analgesia** | Acetaminophen 1000 mg TID. Lidocaine patches (one on each side of the incision). Diclofenac gel for musculoskeletal or joint pain. Ice or heat PRN. | Gabapentin. Ketorolac early on (renal risk). |
| **Muscle relaxant** | Tizanidine | Cyclobenzaprine, methocarbamol |
| **Antiemetic** | 1st: ondansetron. 2nd: low-dose prochlorperazine 2.5–5 mg. | **Scopolamine patch, promethazine** |
| **Promotility** | Low-dose metoclopramide 5 mg TID. Prucalopride 2 mg (no QT prolongation, but off-label and often not covered as an outpatient). | — |
---
## 11. Discharge
### Checklist
- [ ] Follow-up appointment
- [ ] Prescriptions sent to PPV
- [ ] Discharge order
- [ ] Discharge summary
- [ ] Discharge summary routed
### Follow-up Appointment
Send a brief In Basket message to **Stephanie Chavez (chavezst)** and the **HPB Triage Pool** with:
- Date of surgery and procedure (e.g., Whipple)
- When the patient needs to be seen
- Any specific follow-up needs (e.g., staple or drain removal)
Visit type depends on the closure:
- **Staples:** Remove at about 2 weeks. Some patients can see a local surgeon in person but still need a **phone visit with Dr. Sheppard**.
- **Dermabond, or staples already removed:** Phone or virtual follow-up is an option.
### Discharge Summary
1. Write it **after** medication reconciliation is done and all outpatient orders are placed. Refresh the note before signing.
2. Route it to the **HPB Triage Pool, the PCP, and the referring provider** (if listed).
> **Prevent fragmented care.** Make sure every patient has follow-up with their PCP, their medical oncologist, or both. After cancer surgery, 90-day mortality was **0.3%** for patients seen by their PCP vs. **3.3%** for those not seen (Kazaure et al., *JAMA Surg* 2024).
### Discharge Medications
Send to **PPV**, ideally the day before discharge, and earlier if prior authorization is expected.
| Category | Medication and instructions |
|---|---|
| **Acid suppression** (required indefinitely) | Pantoprazole 20 mg daily (40 mg if GERD, DGE, or nausea) × 1 year: **#90 with 3 refills**. After 1 year, continue the PPI or switch to famotidine 20 mg daily or BID. |
| **Multivitamin with iron** (not gummy) | Flintstones Complete (or generic) chewable, **2 tabs/day** (double the label dose), **or** Centrum One-a-Day, 1 tab daily |
| **Nausea** | Ondansetron 4–8 mg ODT q12h PRN: **#15 with 1 refill** |
| **Prokinetic** | Only if used regularly as an inpatient: metoclopramide 5–10 mg TID, a 2-week supply to last until follow-up |
| **Pain** | Acetaminophen 500–1000 mg TID PRN (OTC). Oxycodone or hydromorphone: the **smallest amount**, based on the last 24–48 h of use, to last until follow-up. Gabapentin short-term if it helped as an inpatient (needs a taper plan if > 100 mg/dose). Muscle relaxant: not regularly for > 2 weeks. Lidocaine patches (OTC): only if they helped as an inpatient. |
| **Pancreatic enzymes** | Creon 24,000 or 36,000 capsules with meals and snacks if there are symptoms of insufficiency. **Round the quantity up to the nearest 100** (e.g., 2 per meal + 1 per snack = 9/day × 30 days = 270 → prescribe 300). Send to PPV at least 1 day before discharge. For assistance, see abbvie.com. Alternative: Zenpep. |
| **Bowel regimen** | Senna 8.5 mg PO BID PRN (OTC). MiraLAX 17 g 1–2×/day PRN (order the bottle or jug, not the costlier packets). Lactulose 15–30 g only if used regularly as an inpatient. **No suppositories unless the patient asks.** |
| **Standard (non-pylorus-preserving) Whipple only:** order as OTC, not Rx | Vitamin B12 **sublingual** 500 mcg daily. Calcium citrate 1200–1500 mg/day, split into 2 doses, with meals. Vitamin D3 3000 IU/day **total from all sources** (including the MVI and calcium). |
| **Pancreatic adenocarcinoma** | Apixaban 2.5 mg BID for **30 days total** (subtract hospital days) |
---
## 12. Complications
### Pancreatic Fistula / Leak (Most Common)
A pancreatic fistula is a leak from the pancreatic ductal system into and around the pancreas. It does not have to connect to another epithelialized surface.
| Grade | Definition | Management / impact |
|---|---|---|
| **A** (most common) | Chemical leak: drain amylase > 3× serum amylase. The patient remains clinically well. | Drain stays until the leak resolves. Not counted as a complication; not reportable at M&M. |
| **B** | Requires a change in management | May have trouble with PO intake. CT to look for an undrained collection; may need new or repositioned drains. Antibiotics if there are signs of infection. Delays discharge; may lead to readmission. |
| **C** | Major change in management | May need ICU care. Prolonged hospitalization; associated with complications and mortality. |
### Hemorrhage (Most Serious)
| Timing | Causes |
|---|---|
| **Early** | Technical failure |
| **Late** | Pseudoaneurysm (most often the **GDA**, usually with a pancreatic leak), vascular erosion, ulceration, anastomotic dehiscence |
| Location | Presentation |
|---|---|
| **Intra-abdominal** | Blood in the drain, bleeding from the wound, or intra-abdominal blood on imaging |
| **Intraluminal** | Hematemesis, blood in the NGT, melena |
### Sentinel Bleed
> **Requires urgent action.** A minor bleed through the drain or GI tract often comes before major hemorrhage, followed by a symptom-free interval before **hemorrhagic shock**. Be especially wary on **POD 5–10**, often with a pancreatic leak. Tell nurses to **notify surgery immediately** about any new blood from the drain or GI tract.
1. **Go see the patient.**
2. Get updated vitals and urgent labs: **CBC, CMP, coags, T&S.** Prepare **2 u PRBC**.
3. **Call the senior resident and the attending.**
4. **If stable:** urgent **CTA** for active bleeding. At the same time, call **IR** and tell them the patient may be having a **"sentinel bleed"** (use those words).
5. **Every sentinel bleed goes to the ICU, even if stable**; rebleeding can happen within 48 h. Depending on stability, ICU transfer may come before the CTA.
6. **If unstable:** the patient may need to go **straight to IR without a CTA**.
---
## 13. References
1. D'Angelica MI, et al. Piperacillin-tazobactam compared with cefoxitin as antimicrobial prophylaxis for pancreatoduodenectomy: a randomized clinical trial. *JAMA*. 2023;329(18):1579–1588. https://doi.org/10.1001/jama.2023.5728
2. Ellis RJ, et al. Association between biliary pathogens, surgical site infection, and pancreatic fistula: results of a randomized trial of perioperative antibiotic prophylaxis in patients undergoing pancreatoduodenectomy. *Ann Surg*. 2023;278(3):310–319. https://doi.org/10.1097/SLA.0000000000005955
3. Kazaure HS, et al. Primary care use and 90-day mortality among older adults undergoing cancer surgery. *JAMA Surg*. 2024;159(10):1170–1176.
4. Kumar J, et al. Piperacillin/tazobactam for surgical prophylaxis during pancreatoduodenectomy: meta-analysis. *BJS Open*. 2024;8(3):zrae066. https://doi.org/10.1093/bjsopen/zrae066
5. Nevler A, Yeo CJ. You survived your Whipple operation, now what? Long-term consequences of anemia, incisional hernia, osteopenia, and pathologic fractures. *Adv Surg*. 2025;59(1):223–231. https://doi.org/10.1016/S0065-3411(25)00007-7
6. Phillips ME, et al. Do patients benefit from micronutrient supplementation following pancreatico-duodenectomy? *Nutrients*. 2023;15(12):2804. https://doi.org/10.3390/nu15122804
7. Stein-Thoeringer CK, et al. Microbiome dysbiosis with *Enterococcus* presence in the upper gastrointestinal tract is a risk factor for mortality in patients undergoing surgery for pancreatic cancer. *Ann Surg*. 2025;281(4):615–623. https://doi.org/10.1097/SLA.0000000000006210
---
## 14. Appendix – Abbreviations
### Clinical Terms, Services, and Organizations
| Abbreviation | Meaning |
|---|---|
| A1c | Hemoglobin A1c (glycated hemoglobin) |
| ACS | American College of Surgeons |
| APS | Acute Pain Service |
| ASA | Acetylsalicylic acid (aspirin) |
| ASRA | American Society of Regional Anesthesia and Pain Medicine |
| BG | Blood glucose |
| BiPAP | Bilevel positive airway pressure |
| BP | Blood pressure |
| CA 19-9 | Carbohydrate antigen 19-9 |
| CA-125 | Cancer antigen 125 |
| CBC | Complete blood count |
| CBG | Capillary blood glucose (fingerstick) |
| *C. diff* | *Clostridioides difficile* |
| CEA | Carcinoembryonic antigen |
| CKD | Chronic kidney disease |
| CMP | Comprehensive metabolic panel |
| COR | Consult to the OR (OR scheduling request) |
| CPAP | Continuous positive airway pressure |
| CRP | C-reactive protein |
| CT / CTA | Computed tomography / CT angiography |
| CXR | Chest X-ray |
| DGE | Delayed gastric emptying |
| DHT | Dobhoff tube (nasoenteric feeding tube) |
| diff | Differential (white-cell differential on a CBC) |
| DOAC | Direct oral anticoagulant |
| DVT | Deep vein thrombosis |
| EPI | Exocrine pancreatic insufficiency |
| ESI | Ensure Surgery Immunonutrition |
| EtOH | Ethanol (alcohol) |
| Fr | French (catheter size) |
| GDA | Gastroduodenal artery |
| GERD | Gastroesophageal reflux disease |
| GI | Gastrointestinal |
| GS | General Surgery (order-set prefix) |
| H2 blocker | Histamine-2 receptor antagonist |
| Hgb | Hemoglobin |
| HD | Hemodynamically |
| HOB | Head of bed |
| HPB | Hepato-pancreato-biliary |
| ICU | Intensive care unit |
| IPMN | Intraductal papillary mucinous neoplasm |
| IR | Interventional radiology |
| IS | Incentive spirometer |
| IV / IVF | Intravenous / intravenous fluids |
| LE | Lower extremity |
| LFTs | Liver function tests |
| LR | Lactated Ringer's |
| M&M | Morbidity and mortality conference |
| MN | Midnight |
| MVI | Multivitamin |
| Na | Sodium |
| NG / NGT | Nasogastric / nasogastric tube |
| NPO | *Nil per os* (nothing by mouth) |
| NRT | Nicotine replacement therapy |
| NS | Normal saline |
| NSAID | Nonsteroidal anti-inflammatory drug |
| N/V | Nausea and vomiting |
| ODT | Orally disintegrating tablet |
| OHSU | Oregon Health & Science University |
| OR | Operating room |
| OTC | Over the counter |
| P2Y12 inhibitor | Platelet ADP-receptor (P2Y12) antagonist |
| PCA | Patient-controlled analgesia |
| PCN | Penicillin |
| PCP | Primary care provider |
| PEG | Polyethylene glycol (MiraLAX) |
| PERT | Pancreatic enzyme replacement therapy |
| PEth | Phosphatidylethanol (alcohol-use biomarker) |
| PICC | Peripherally inserted central catheter |
| PIV | Peripheral IV |
| PMC | Not defined in the source (an OHSU clinic that assesses frailty; confirm locally) |
| PO | *Per os* (by mouth) |
| POD | Post-operative day |
| PPI | Proton pump inhibitor |
| PPV | Not defined in the source (the OHSU outpatient pharmacy that receives discharge prescriptions; confirm locally) |
| PR | *Per rectum* |
| PRBC | Packed red blood cells |
| PT / OT | Physical therapy / occupational therapy |
| PV | Portal vein |
| QT | QT interval (ECG) |
| RAI | Risk Analysis Index (frailty score) |
| RN | Registered nurse |
| Rx | Prescription |
| SCD | Sequential compression device |
| SMV | Superior mesenteric vein |
| SNF | Skilled nursing facility |
| T&S | Type and screen |
| TPN | Total parenteral nutrition |
| TSICU | Trauma/Surgical Intensive Care Unit |
| WATSA | Whipple At The Splenic Artery |
### Dosing Frequency and Units
| Abbreviation | Meaning |
|---|---|
| BID | Twice daily |
| TID | Three times daily |
| QHS | Every night at bedtime |
| q*N*h | Every *N* hours (e.g., q8h = every 8 hours) |
| PRN | As needed |
| g / mg / mcg | Gram / milligram / microgram |
| IU | International units |
| kg | Kilogram |
| mL/hr | Milliliters per hour |
| u | Units (of blood product) |